Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Setmelanotide

Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity

Rhythm · Phase 3 · Completed · Enrollment 12

NCT04966741

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Setmelanotide: PPL Groupn/rn/rn/rn/r
Setmelanotide: BBS Groupn/rn/rn/rn/r

Not shown

  • Setmelanotide: PPL Group: endpoint not reported
  • Setmelanotide: BBS Group: endpoint not reported